When analyzed within a consistent framework accounting for exit screening and follow-up timing, #Mammography trials yield consistent excess-incidence patterns compatible with very low overdiagnosis (<5%). Read the data here🔽 bit.ly/4BlejoW #BreastCancer @JNCI_Now

Prophylactic goshajinkigan (a traditional Japanese herbal medicine) reduced the incidence of grade 2 or higher chemotherapy-induced peripheral neuropathy in patients receiving carboplatin plus paclitaxel. Full article: bit.ly/4AWnKuy

From the 2026 ONA Summit: Personal Experience With NF1 Shapes Oncology Nurse’s Approach to Care Read our feature article here: bit.ly/4BaxQIC

Monitoring CNS symptoms in patients receiving olanzapine during chemotherapy helps identify those at risk of CNS symptom burden, though the antiemetic efficacy of the therapy is not reduced. Read more about this study from @OncJournal here: bit.ly/47gRc0Y

Male #BreastCancer survivors face social, physical, and psychological distress postdiagnosis, using varied coping strategies and support to navigate self-reconstruction Read more about the study: bit.ly/4AVx81z

Following axi-cel infusion, older patients with #LBCL demonstrated clinically significant improvements in immediate verbal and delayed memory that eliminated baseline cognitive disparities with younger patients Read more: bit.ly/4rQahk1

A new global analysis indicated that second-hand smoke exposure continues to impose a substantial health burden despite declines in exposure prevalence 🚭 Source: @TheLancetPH Read the full article: bit.ly/4yEn37K

An online survey from @RPuddRN found 90% of #OncNurses lack confidence in discussing geonomics risks Those surveyed scored 38.8% on a geonomics knowledge assessment and 94% recognized the importance of further education. 📖 Read all the findings here: bit.ly/4hKLjhd

Quarterly nursing quality summits help in achieving and sustaining zero harm in #OncologyCare Curious about the ways in which these summits have helped inpatient #OncNurses? Read our feature here🔽 bit.ly/4egjHiW

Pain catastrophizing independently predicted #Cancer pain intensity and statistically accounted for part of the difference in pain intensity (Source: @MASCC_JSCC) 🔗Read more about this study here: bit.ly/4rJQ3YR

#RareCancers are uncommon, but together they represent ~20% of all cancer cases. 🎗️ On #RareCancerDay, we spotlight #OncNurses in advocating for early genomic testing, clinical trial access, and tailored care pathways. How does your clinic support rare cancer patients? 👇

A study in @FrontPsychol explores why 60%–70% of young #BreastCancer survivors (ages 18–40) experience moderate-to-high fear of cancer recurrence. Read more about the study here: bit.ly/4xJh28l

This week was #WorldCancerResearchDay! Thank you to the researchers whose work has improved many patients' QoL and helped them live longer, healthier lives! ❤️

#ColorectalCancer in many cases has genomic underpinnings that the oncology nurse should be aware of, according to a presentation at #ONSBridge2026 by @KCalzone, a research geneticist at the @theNCI Read about her research here: bit.ly/4AwVJti

Researchers have published the Core Competency Framework for Precision Oncology in @eClinicalMed to help build a genomics-capable healthcare workforce, including #OncNurses Read the full article here: bit.ly/4xvOPBP

A new study suggests spirituality can be a key factor in shared decision-making for patients being treated in the oncology setting Source: the Scandinavian Journal of Caring Sciences Read our article: bit.ly/4cR9oBu

It's #WorldLymphomaAwarenessDay! 💚 Metformin maintenance was associated with improved treatment response and survival among patients with diffuse large B-cell #Lymphoma (#DLBCL) and #HGBL! Read about the research here: bit.ly/4Ab8I3K

September is #ProstateCancerAwarenessMonth 🩵 We recently published a guide to PTEN-deficient mCSPC for patients and practitioners Read more about this aggressive form of #ProstateCancer: bit.ly/4itJO9g

New from @PsyOnc: Over 53% of cancer outpatients reported clinically significant distress, yet 55.6% of those in high distress received no referral. Link to the full article: bit.ly/4xROGtG

A study in the @CANO_ACIO finds that tailored education helps breast and #ColorectalCancer survivors better use Survivorship Care Plans when transitioning to primary care, supporting autonomy and continuity of care. 🎗️ Read our article: bit.ly/4daR863 #OncNurses